Borrowed Funds
Borrowed funds at December 31, 2025 and 2024 consist of the following:
FHLB AdvancesSubordinated Debt, net
2025202420252024
Balance Outstanding at December 31,$— $50,000 $18,750 $18,695 
Maximum balance at any month end during the year$50,000 $118,000 $18,750 $19,675 
Average balance for the year$39,182 $79,874 $18,721 $19,613 
Weighted average rate on borrowings for the year ended3.74 %4.37 %6.06 %5.23 %
The Company had no FHLB advances at December 31, 2025 and had $50.0 million at December 31, 2024. At December 31, 2025, collateral pledged with FHLB included the following: 1-4 family residential loans with a lendable value of $142.2 million, multi-family residential loans with a lendable value of $35.9 million, home equity lines of credit with a lendable value of $2.0 million and commercial real estate loans with a lendable value of $150.5 million. The available line of credit with the FHLB totaled $694.4 million at December 31, 2025, and the excess lendable collateral value at December 31, 2025 totaled $211.4 million. The Bank has a letter of credit with the FHLB in the amount of $130.0 million for the purpose of providing collateral for Virginia public deposits. The remaining lendable collateral value at December 31, 2025 totaled $389.0 million.
The Company had unsecured lines of credit with correspondent banks available for overnight borrowing which totaled $209.2 million and $184.0 million at December 31, 2025 and 2024, respectively. At December 31, 2025 and 2024, the Company had no advances on these lines outstanding.
At December 31, 2025 and 2024, the Company had pledged commercial loans to the FRB to secure a borrowing capacity totaling $256.7 million and $153.4 million, respectively, under its discount window program. At December 31, 2025 and 2024, the Company had no advances with the FRB discount window.
On October 13, 2020, the Company completed a private placement of $20 million of its 4.875% fixed-to-floating subordinated notes due 2030 (the "Notes") to certain qualified institutional buyers and accredited investors. The Notes have a maturity date of October 15, 2030 and carry a fixed rate of interest of 4.875% for the first five years. Thereafter, the Notes will pay interest at the then current three-month Secured Overnight Financing Rate plus 471 basis points, resetting quarterly. The Notes include a right of prepayment without penalty on or after October 15, 2025. The Company used the proceeds from the placement of the Notes for general corporate purposes, including to support capital ratios at the Bank, and the repayment of previously issued subordinated debt which was called in August 2021. The Notes qualify as Tier 2 capital for the Company to the fullest extent permitted under the Basel III capital rules. When contributed to the capital of the Bank, the proceeds of the subordinated notes may be included in Tier 1 capital for the Bank. The Company paid approximately $984 thousand to repurchase and retire a portion of the notes in 2024.

Historical Timeline

Fiscal YearFiled
2025Mar 16, 2026Showing above
2024Mar 20, 2025
2023Mar 21, 2024
2022Mar 24, 2023

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.